Randomized controlled trial of hydrochlorothiazide in augmenting the dose of 131I absorbed by thyroid remnant

Journal of Sichuan University (Medical Science)

Volumn 35, Issue 4, 2004, Pages 546-548

  Ding, Hao ^a   Kuang, An Ren ^a   Guan, Chang Tian ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Differentiated thyroid carcinoma; Hydrochlorothiazide 131I

Indexed keywords

HYDROCHLOROTHIAZIDE; IODINE 131; PLACEBO;

ARTICLE; CANCER RECURRENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABSORPTION; HUMAN; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; THYROID CARCINOMA; THYROID SURGERY;

EID: 3442886540     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. 131I Excretion Facilitated by salt and water. J Clin Pharmacol, 1981;21(5 - 6):201.
2. Maruca J, Santner S, Miller K, et al. Prolonged iodine clearance with a depletion regimen for thyroid carcinoma: concise communication. J Nucl Med, 1984;25(10):1089.
3. Berg GEB, Michanek AMK, Hoimberg ECV, et al. Iodine-131 Treatment of Hyperthyroidism: significance of Effective Half-life Measurements. J Nuck Med, 1996;37(2):228.
4. 131I Therapy of Metastatic, Well Differentiated Thyroid Carcinoma. J Clin Endocrinol Metab, 1999;84(3):912.